Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding trial of topical ibuprofen gel concentrations in actinic keratosis
2012-002529-30Phase 2Completed
- Sponsor
- Dolorgiet GmbH & Co. KG
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen in actinic keratosis (AK) (3 arms), sponsored by Dolorgiet GmbH & Co. KG. Primary endpoint: Change of Target Lesion Number Score. Started Sep 2012; status: completed.
02
Drugs
ibuprofen
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2012-002529-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002529-30.